A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab
| Image |  |
|---|---|
| Description | scientific article published on January 26, 2013 |
| Author/s |
author: Brian G. Feagan William Jeffery Sandborn Fernando S Velayos |
| Publication date | January 26, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |